Senior Research Scientist - Cell Biology & Tissue Models
Bengaluru, India · Full time · Posted Oct 7, 2026
Role Overview
We are seeking a hands-on Senior Research Scientist to lead the development and application of cell-based assays and three-dimensional tissue models within Pandorum’s Cellular Engineering team. The position combines mammalian cell culture, disease-relevant model development, biochemical analysis and evaluation of biological activity.
Required Qualifications
Ph.D. in Biotechnology, Cell Biology, Molecular Biology, Biochemistry, Bioengineering, Regenerative Medicine, Stem Cell Biology, Pharmacology, Neuroscience or a related life-science discipline.
Experience: Typically 3–6 years of relevant post-Ph.D. research or industry experience; demonstrated scientific independence and directly relevant expertise will guide assessment..
Key Responsibilities
Perform biochemical, molecular and cell-based assays; analyze results and maintain complete laboratory records.
Design controlled experiments with predefined objectives, appropriate comparators and biological replication; retain complete records and critically assess all findings.
Establish, maintain and characterize human cellular, multicellular and 3D tissue models, including spheroids or organoids appropriate to the research question.
Develop and qualify assays for biological activity in disease-relevant systems, drawing on expertise in inflammation, fibrosis and tissue repair.
Characterize experimental materials using appropriate biochemical and molecular methods, and perform quantitative cell-based assays.
Evaluate concentration-dependent and time-dependent responses, model reproducibility and tissue-relevant function alongside viability and appropriate controls.
Work with colleagues to investigate assay variability, establish suitable controls and improve method reproducibility.
Prepare technical reports, present findings and contribute to assay transfer and preclinical study documentation.
Own experimental plans and milestones, maintain SOPs and technical reports, communicate findings clearly and mentor junior team members.
Preferred Experience
Experience with quantitative imaging, molecular assays and integration of structural and functional readouts; assay transfer or collaboration with external research laboratories.
Strong hands-on mammalian cell-culture, cell-biology and molecular-biology skills, with evidence of independent experimental design, troubleshooting and quantitative data interpretation.
Ability to perform and interpret biochemical or molecular characterization alongside quantitative cell-based assays, with clear documentation and scientific communication.
Demonstrated independent ownership of disease-relevant assay development, including hands-on establishment and characterization of at least one human 3D culture, spheroid, organoid or multicellular tissue model.
Scientific depth in inflammation, fibrosis, tissue repair, neurobiology or a related area, with the ability to apply that expertise across experimental systems.
Working understanding of cellular signaling, gene expression and molecular mechanisms relevant to cell-based research.
Experience with organoid development, stem-cell differentiation or advanced human co-culture models.
Experience with induced pluripotent stem cell (iPSC) maintenance and characterization, directed differentiation, or neuronal/glial cultures.
Experience with extracellular-vesicle (EV) biology, biochemical characterization or functional and potency assays.
Ovii Interpretation
This Senior Research Scientist role develops cell-based assays and three-dimensional tissue models for cellular engineering research. The work combines mammalian cell culture, disease-relevant model development, biochemical and molecular characterization, and evaluation of biological activity.
Establish, maintain, and characterize human cellular, multicellular, and 3D tissue models, including spheroids or organoids.
Design controlled experiments with defined objectives, comparators, and biological replication; analyze findings critically.
Develop and qualify assays for biological activity in disease-relevant systems, including inflammation, fibrosis, and tissue repair.
Characterize experimental materials and evaluate concentration- and time-dependent responses, viability, reproducibility, and tissue-relevant function.
Investigate assay variability with colleagues, define suitable controls, and improve method reproducibility.
Maintain complete laboratory records, SOPs, and technical reports; document preclinical study work.
Own experimental plans and milestones, present findings, contribute to assay transfer, and mentor junior team members.
Good fit signals
Holds a Ph.D. in a relevant life-science discipline and brings typically 3–6 years of relevant postdoctoral or industry research experience.
Can independently design experiments, troubleshoot methods, interpret quantitative data, and document findings clearly.
Has hands-on experience with human 3D culture, spheroid, organoid, or multicellular tissue models; this is a preferred experience signal.
Scientific depth in inflammation, fibrosis, tissue repair, neurobiology, or a related area can be useful across experimental systems.
Experience with assay transfer, external research collaborations, iPSC methods, or extracellular-vesicle biology is advantageous.
Meet Pandorum
Pandorum Technologies is a Bengaluru-based biotechnology company developing programmable regenerative medicines and engineered human tissues. Founded in 2011, its platform combines biomaterials, cellular engineering, designer exosomes and biofabrication to promote tissue repair and regeneration. Its lead therapeutic, Kuragenx, is a cell-free exosome-based treatment for severe corneal diseases and has received US FDA Orphan Drug Designation. Pandorum also develops 3D human liver organoids for drug research and regenerative approaches for lung and other tissues. The company operates R&D activities in India and the United States and collaborates with clinical and manufacturing partners including Northwestern Medicine, Medical University of South Carolina and Nucelion Therapeutics.
Founded
2011
Company size
11-50 employees
Company stage
Not known
Headquarters
Bengaluru, India
Why work here
Pandorum offers scientists and engineers the opportunity to work on clinical-stage regenerative medicine spanning designer exosomes, stem-cell biology, biomaterials, organoids and advanced biofabrication. Its lead therapy Kuragenx has received US FDA Orphan Drug Designation, and the company raised an $18 million Series B in 2026 to advance clinical development and global manufacturing. Pandorum also collaborates with clinical and manufacturing organizations in India and the US. Its careers page lists health and life insurance, family medical coverage, annual health checks, mental-health support and competitive compensation, while emphasizing continuous learning. Candidates should also consider the long validation, regulatory and clinical-development cycles inherent to biotechnology.
TBTuhin BhowmickCo-Founder, CEO and DirectorView bioHide bio
Co-founder, CEO and Director. Bhowmick holds a PhD from the Indian Institute of Science and completed postdoctoral research at the European Molecular Biology Laboratory as an EMBO-Marie Curie fellow. His expertise includes biophysics, biomaterials, structural biology, protein biochemistry and computational biology.
ACArun ChandruCo-Founder, CTO and DirectorView bioHide bio
Co-founder, CTO and Director. Chandru completed research in Aerospace Engineering at the Indian Institute of Science, where he received a gold medal for best thesis. His expertise spans systems engineering, advanced manufacturing and biofabrication. He was named to Forbes Asia's 30 Under 30 Healthcare & Science list in 2016.
SRSridhar RanganathanSenior Advisor - Commercialization and Strategic PartnershipsView bioHide bio
Advises Pandorum on commercialization and strategic partnerships. Ranganathan has more than three decades of healthcare experience and previously served as Managing Director of Allergan India and Associate Vice President at Allergan International, with expertise in ophthalmology, medical devices and healthcare commercialization.
Pandorum and Nucelion manufacturing partnership to advance two designer-exosome programmes in ophthalmology
BioSpectrum India·
Pandorum and Bharat Biotech subsidiary Nucelion Therapeutics expanded their manufacturing partnership to support two PRIP-backed ophthalmology programs targeting advanced keratopathy and wet age-related macular degeneration. The programs use Pandorum's designer-exosome regenerative-medicine platform.
Pandorum Technologies raises $18 million in Series B to scale tissue regenerative therapies
ET Pharma·
Pandorum closed an $18 million Series B round to advance clinical development of Kuragenx and other tunable exosome-based therapies, expand manufacturing capacity and grow operations across the United States, Japan and the Middle East.
Pandorum Technologies and Nucelion Therapeutics announce strategic manufacturing collaboration for ocular regenerative therapies
Business Wire·
Pandorum partnered with Nucelion Therapeutics to build manufacturing capabilities for its exosome-based ocular regenerative therapies across Asia-Pacific, supporting clinical development, regional supply and regulatory readiness.